⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3379951 | 1.00 | — | — | |
| SCHEMBL17628680 | 0.79 | — | — | |
| SCHEMBL20893628 | 0.77 | — | — | |
| SCHEMBL3378562 | 0.77 | — | — | |
| SCHEMBL20893629 | 0.77 | — | — | |
| SCHEMBL3378563 | 0.77 | — | — | |
| SCHEMBL3802042 | 0.75 | — | — | |
| SCHEMBL287734 | 0.75 | — | — | |
| SCHEMBL3864471 | 0.75 | TP53 (0.36) | — | |
| SCHEMBL163127 | 0.73 | TP53 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010017405-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN | HELLER ADAM (US) | 2010-02-11 | — | — | WO | claimed |
| US-11814739-B2 | Electrolytic production of organic chloramine solutions | DE NORA HOLDINGS US, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| EP-3469117-B1 | ELECTROLYTIC PRODUCTION OF ORGANIC CHLORAMINE SOLUTIONS | DE NORA HOLDINGS US INC (US) | 2022-01-26 | — | — | EP | disclosed |
| US-20190345620-A1 | ELECTROLYTIC PRODUCTION OF ORGANIC CHLORAMINE SOLUTIONS | DE NORA HOLDINGS US, INC. | 2019-11-14 | — | — | US | disclosed |
| EP-3469117-A1 | ELECTROLYTIC PRODUCTION OF ORGANIC CHLORAMINE SOLUTIONS | Johnson Matthey Public Limited Company (GB) | 2019-04-17 | — | — | EP | disclosed |
| WO-2010017405-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN | HELLER ADAM (US) | 2010-02-11 | — | — | WO | disclosed |